Skip to main content
Lab In the News
Contact the Lab

Oro Lab in the News

Resistance is Futile - Closing Cancer Cell's Escape Route

Stanford Medicine  Article 2021

Read the News

Lab in the News

Video Title Image

Tony interviewed about manufacturing autologous tissue stem cells by Dr. Russ Altman on Stanford's "Future of Everything"   March 20, 2019

Watch the Interview
New Treatment Identified for Drug Resistant Basal Cell Carcinomas

February 5, 2018

Read Commentary
2nd Annual Center for Definitive and Curative Medicine Symposium

February 27, 2018

"Innovations in the Pipeline to Curative Medicines"
See Program
Tony named Co-Director of the Stanford Child Health Research Institute

September 1, 2017

View Announcement
Oro lab and EB iPS Consortium awarded $5M California Institute of Regenerative Medicine Grant for Innovative Skin Stem Cell Therapy

December 7, 2017

View Announcement
1st Annual Center for Definitive and Curative Medicine Symposium 

February 3, 2017

"Curing the Incurable through Definitive Medicine"
See the Symposium Agenda
Inside Stanford Medicine
"Stanford announces new Center for Definitive and Curative Medicine"

July 24, 2017

View Commentary
Annual Center

First Stanford Child X Conference April 2, 2015

Definitive Stem Cell & Gene Therapy for Child Health

Tony gives talk on the potential for autologous, genetically-corrected, induced pluripotent cell-derived tissue stem cells for genetic diseases like Epidermolysis bullosa

Watch Tony's ChildX interview Watch Tony's ChildX Talk
SM
Inside Stanford Medicine
"Stanford’s lab for cell, gene medicine opens in Palo Alto"

September 6, 2016

View Commentary
Inside Stanford Medicine
"Skin tumors develop specific mutations to resist drug, researchers say"

March 9, 2015

View Commentary
Cancer Cell
Vismodegib Resistance in Basal Cell Carcinoma: Not a Smooth Fit

March 9, 2015

Read Commentary

Therapeutic Reprogramming for the Treatment of Epidermolysis Bullosa

Inside Stanford Medicine
"Blistering skin disease may be treatable with 'therapeutic reprogramming,' researchers say"

Nov 26, 2014

View Commentary
MNT
Medical News Today
"'Therapeutic reprogramming' may lead to treatment for epidermolysis bullosa, a blistering skin disease"

Dec 1, 2014

View Commentary

Identification of the Atypical Protein Kinase C in Tumor Resistance

SM
Inside Stanford Medicine
"Discovery opens door to multipronged attack against common skin cancer, study shows"

Feb 27, 2013

View Commentary
SFO Business Times
San Francisco Business Times
"Catching the Hedgehog: Stanford researchers uncover new way to block cancers"

Feb 27, 2013

View Commentary